D. I. R. Albayati and D. A. Oday Hatem, “Effectiveness and Safety of Ocrelizumab in Primary Progressive Multiple Sclerosis among Iraqi Patients”, WOS, vol. 2, no. 3, pp. 86–91, Mar. 2025.